New cancer institute鈥檚 world-leading research and treatment
A new cancer institute in South Australia will deliver world-leading patient care, cutting-edge cancer diagnoses and treatments, and ground-breaking research.
The new South Australian immunoGENomics Cancer Institute (SAiGENCI) has been established with $80 million in funding from the Australian Government, and builds on the collective efforts of the University of 米兰电子, the State Government of South Australia and the Central 米兰电子 Local Health Network (CALHN).
SAiGENCI will join a network of the world鈥檚 leading cancer research institutes to meet the global challenge of developing innovative, new treatments for cancer patients, including in Australia.